Return To 1 billion for synthetic pharma royaltie

$1 billion for ‘synthetic’ pharma royalties

Fortune | By Dan Primack

Cowen Healthcare Royalty Partners today is expected to announce that it has closed its second fund with a whopping $1 billion in capital commitments.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Powered by  GDPR Cookie Compliance